Key takeaways:

• How to BUILD a successful Medtech company from scratch
• Investor to CEO: Learn how to SCALE success
• Ahead of the GAME: How to avoid common mistakes that Medtech startups make
• Building a STRONG company culture 

About David:
David Fischel has served as CEO and Chairman of Stereotaxis since February 2017. He joined Stereotaxis as a Director in late 2016 after orchestrating a transformative equity investment in the company. Mr. Fischel has served for over ten years as Principal and portfolio manager for medical device investments at DAFNA Capital Management, LLC. Prior to joining DAFNA Capital, he was a research analyst at SCP Vitalife, a healthcare venture capital fund. Mr. Fischel completed his B.S. magna cum laude in Applied Mathematics with a minor in Accounting at the University of California at Los Angeles and received his MBA from Bar-Ilan University in Tel Aviv. He is a Certified Public Accountant, Chartered Financial Analyst and Chartered Alternative Investment Analyst.

Stereotaxis is the global leader in innovative robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. Its mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide unsurpassed patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information.

Career inspiration, medtech opportunities, hiring solutions and market insights, all in one place. Find them here.